slno,preds
0,"## Answer
The pathology report provides the following information:

- The tumor is a poorly differentiated invasive ductal carcinoma, which is classified as G3 (grade 3).
- The tumor measures 55 mm.
- There is invasion of lymph vessels and focal invasion of blood vessels.
- There is infiltration of the overlying epidermis with slight erosion and extension to the basal resection margin.
- The tumor classification is given as pT4b, pLI, pV1, pN1a (1/11), pMx.
- The stage is explicitly mentioned as stage III B.

Breaking down the classification:
- pT4b indicates a tumor of any size with direct extension to the chest wall and/or skin (ulceration or skin nodules).
- pN1a indicates metastasis to 1-3 axillary lymph nodes.
- pMx indicates that distant metastasis cannot be assessed.

According to the AJCC staging system:
- Stage III B includes T4 tumors with any N and M0, or any T with N2 and M0.

The report explicitly states the stage as III B, which aligns with the provided tumor classification and characteristics.

Therefore, the answer is - 
{""stage"" : ""Stage III""}"
1,"## Answer
The pathology report provides the following information:

- Diagnosis: Breast Cancer
- Histological description: Infiltrative ductal carcinoma
- Grade: 2
- T Stage: 2
- N Stage: 0
- M Stage: 0

The AJCC staging system for breast cancer is based on the TNM classification:

- T (Tumor): T2 indicates a tumor size greater than 2 cm but not more than 5 cm.
- N (Nodes): N0 indicates no regional lymph node involvement.
- M (Metastasis): M0 indicates no distant metastasis.

Based on the TNM classification provided (T2, N0, M0), we can determine the AJCC stage:

- Stage I: T1, N0, M0
- Stage II: T2, N0, M0 or T1, N1, M0
- Stage III: T3, N0, M0 or T2, N1, M0, etc.
- Stage IV: Any T, Any N, M1

The patient's classification of T2, N0, M0 corresponds to Stage II breast cancer.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
2,"## Answer
To determine the AJCC stage of the cancer, we need to interpret the TNM classification provided in the pathology report:

1. **Tumor (T) Classification**: 
   - The report states ""pT4b"". According to the AJCC staging system, T4b indicates a tumor of any size with direct extension to the chest wall and/or skin (ulceration or skin nodules).

2. **Node (N) Classification**: 
   - The report states ""N3a"". N3a indicates metastasis in 10 or more axillary lymph nodes, or in infraclavicular (level III axillary) lymph nodes.

3. **Metastasis (M) Classification**: 
   - The report does not mention distant metastasis (M0 or M1), but since it is not specified, we assume M0 (no distant metastasis) for staging purposes.

4. **Additional Information**:
   - The report mentions ""focal ulceration of the skin"" which supports the T4b classification.
   - ""G III"" indicates a poorly differentiated tumor, which is a high-grade tumor.

Based on the TNM classification:
- T4b (tumor with skin involvement)
- N3a (extensive lymph node involvement)
- M0 (assumed, as not specified)

According to the AJCC 8th edition staging system for breast cancer:
- T4b, N3a, M0 corresponds to Stage IIIC.

Therefore, the answer is - 
{""stage"" : ""Stage III""}"
3,"## Answer
To determine the AJCC stage of the cancer, we need to consider the TNM classification provided in the pathology report:

1. **Tumor size (T):** The report indicates two foci of invasive lobular carcinoma measuring 1.9 cm and 2.2 cm. According to the AJCC 7th edition, a tumor size greater than 2 cm but not more than 5 cm is classified as T2.

2. **Lymph Nodes (N):** The report states that there are 0/4 sentinel lymph nodes involved, which means there is no regional lymph node metastasis. This is classified as N0.

3. **Metastasis (M):** The report indicates MX, which means distant metastasis cannot be assessed. However, there is no evidence of distant metastasis provided in the report.

Based on the TNM classification:
- T2 (tumor size between 2 and 5 cm)
- N0 (no regional lymph node involvement)
- MX (distant metastasis cannot be assessed, but no evidence of metastasis is provided)

According to the AJCC staging system, a T2, N0, M0 classification corresponds to Stage II breast cancer.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
4,"## Answer
The pathology report provides the following key information:

1. **Tumor Size and Characteristics**: The right breast has a moderately differentiated infiltrating ductal carcinoma with a nuclear grade of III/III and a high mitotic index. The invasive carcinoma spans a microscopic distance of 2.6 cm. There are minor foci of ductal carcinoma in situ, but over 90% of the tumor is invasive.

2. **Margins**: The tumor extends to the superficial margin, but the medial margin is free of tumor by 5 mm, and the deep margin is free by approximately 1 cm.

3. **Lymph Nodes**: 
   - Sentinel Node #1 shows no evidence of metastatic disease.
   - Sentinel Node #2 has an isolated tumor cell cluster of 0.1 mm in a capsular lymphatic space, confirmed by positive cytokeratin immunohistochemical staining.

4. **Distant Metastasis**: There is no mention of distant metastasis in the report.

Based on the AJCC staging system:
- **T (Tumor size and extent)**: The primary tumor is 2.6 cm, which corresponds to T2 (tumor more than 2 cm but not more than 5 cm in greatest dimension).
- **N (Regional lymph nodes)**: Sentinel Node #2 has isolated tumor cells, which is often considered N0(i+) (isolated tumor cells in regional lymph node(s) no greater than 0.2 mm).
- **M (Distant metastasis)**: There is no evidence of distant metastasis, so M0.

Given these factors, the cancer is classified as Stage IIA (T2, N0(i+), M0) according to the AJCC staging system.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
5,"## Answer
The pathology report provides the following key information for staging:

1. **Tumor Size (T Stage)**: The tumor is described as infiltrating duct carcinoma with a size of 0.9 cm. The pathologic T stage is given as pT1b, which corresponds to a tumor size greater than 0.5 cm but not more than 1 cm.

2. **Lymph Node Involvement (N Stage)**: The report states that there is no lymph node involvement, with 0 out of 2 lymph nodes positive for tumor. The pathologic N stage is pN0, indicating no regional lymph node metastasis.

3. **Distant Metastasis (M Stage)**: The pathologic M stage is pMX, meaning that distant metastasis cannot be assessed from the information provided.

Based on the AJCC (American Joint Committee on Cancer) staging system for breast cancer:

- **Stage I** is characterized by a small tumor (T1) with no lymph node involvement (N0) and no distant metastasis (M0). Specifically, Stage I includes T1 (subcategories T1mi, T1a, T1b, T1c) N0 M0.

Given the information:
- T stage is pT1b (tumor size >0.5 cm but ≤1 cm),
- N stage is pN0 (no lymph node involvement),
- M stage is pMX (distant metastasis cannot be assessed, but typically assumed M0 for staging unless proven otherwise),

The cancer fits the criteria for Stage I.

Therefore, the answer is - 
{""stage"" : ""Stage I""}"
6,"## Answer
To determine the AJCC stage of the breast cancer from the pathology report, we need to consider the tumor size, lymph node involvement, and any distant metastasis.

1. **Tumor Size (T):** The report indicates an infiltrating ductal carcinoma with a size of at least 3 cm in greatest dimension. According to AJCC staging, a tumor size of 2-5 cm corresponds to T2.

2. **Lymph Node Involvement (N):** The report mentions metastatic carcinoma in two of twenty-one lymph nodes. This indicates N1, which is defined as metastasis in 1-3 axillary lymph nodes.

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, so we assume M0.

Combining these factors:
- T2 (tumor size 2-5 cm)
- N1 (metastasis in 1-3 axillary lymph nodes)
- M0 (no distant metastasis)

According to the AJCC 8th edition staging system for breast cancer, T2 N1 M0 corresponds to Stage IIB.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
7,"## Answer
To determine the AJCC stage of the cancer, we need to consider the TNM classification provided in the pathology report:

1. **Tumor (T) Classification**: 
   - The report states ""pT1b(m)"". According to the AJCC 7th edition, T1b indicates a tumor size greater than 5 mm but not more than 10 mm. The main lesion is 6 mm, which fits this classification.

2. **Node (N) Classification**: 
   - The report states ""NO(sn)"", which means there is no regional lymph node metastasis. The sentinel nodes examined were negative for metastatic carcinoma (0/2).

3. **Metastasis (M) Classification**: 
   - The report states ""Mx"", indicating that distant metastasis cannot be assessed. However, there is no evidence provided in the report of distant metastasis.

Based on the TNM classification:
- T1b: Tumor size greater than 5 mm but not more than 10 mm.
- N0: No regional lymph node metastasis.
- Mx: Distant metastasis cannot be assessed, but no evidence of metastasis is provided.

According to the AJCC staging system, a T1b, N0, M0 classification corresponds to Stage I breast cancer.

Therefore, the answer is - 
{""stage"" : ""Stage I""}"
8,"## Answer
To determine the AJCC stage of the cancer, we need to consider the tumor size, lymph node involvement, and presence of metastasis.

1. **Tumor Size (T):** The pathology report indicates an invasive ductal carcinoma in the left breast measuring 1.8 cm in largest dimension. According to AJCC staging, a tumor size of 1.8 cm falls under T1 (specifically T1c, which is >1 cm but ≤2 cm).

2. **Lymph Node Involvement (N):** The report states that all sentinel and non-sentinel lymph nodes examined from the left axilla are benign (0/1, 0/4, 0/1, 0/2), indicating no lymph node involvement. This corresponds to N0.

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, so we assume M0.

Combining these factors, the cancer is classified as T1cN0M0, which corresponds to Stage I according to the AJCC staging system.

Therefore, the answer is - 
{""stage"" : ""Stage I""}"
9,"## Answer
To determine the AJCC stage of the cancer, we need to consider several factors from the pathology report: tumor size, lymph node involvement, and metastasis.

1. **Tumor Size (T):** The report states that the tumor size is 3.0 cm. According to AJCC staging, a tumor size of 2-5 cm is classified as T2.

2. **Lymph Node Involvement (N):** The report does not mention any lymph node involvement. Without specific information on lymph nodes, we assume N0 (no regional lymph node metastasis).

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, so we assume M0 (no distant metastasis).

Based on the above information:
- T2 (tumor size 2-5 cm)
- N0 (no lymph node involvement)
- M0 (no distant metastasis)

According to the AJCC staging system, a T2, N0, M0 breast cancer is classified as Stage II.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
10,"## Answer
The pathology report provides the following key information for staging the cancer:

1. **Tumor Size and Invasion**: 
   - The invasive carcinoma is measured at 1.0 x 1.0 x 0.6 cm, which falls under the T1 category. However, the report mentions a pT2 classification, likely due to the presence of a separate mass of intraductal and infiltrating ductal carcinoma measuring 2.5 cm, which could contribute to the overall tumor size consideration.

2. **Lymph Node Involvement**: 
   - Sentinel lymph nodes #1 and #2 are negative for tumor involvement (0/2), indicating N0 status.

3. **Metastasis**: 
   - The report lists MX, meaning distant metastasis cannot be assessed, but there is no indication of metastasis in the provided information.

4. **Additional Features**: 
   - The report mentions high nuclear grade and associated ductal carcinoma in situ (DCIS), but these do not directly affect the AJCC stage.

Given the information:
- The tumor size and characteristics suggest a T2 classification.
- There is no lymph node involvement (N0).
- Metastasis is not assessed (MX), but typically, if there were known metastases, it would be indicated.

Based on the TNM classification provided (pT2, N0, MX), the cancer is classified as Stage II according to the AJCC staging system, as Stage II typically includes T2, N0, M0.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
11,"## Answer
The pathology report provides the following key information for staging:

1. **Tumor Size and Characteristics**: The invasive tumor is 3.5 cm in its greatest dimension, which corresponds to a T2 classification (tumor size >2 cm but ≤5 cm).

2. **Lymph Node Involvement**: There are 3 out of 28 lymph nodes positive for metastatic adenocarcinoma, with extracapsular extension noted. This corresponds to an N1 classification (metastasis in 1-3 axillary lymph nodes).

3. **Distant Metastasis**: The M stage is reported as pMX, indicating that distant metastasis cannot be assessed from the information provided.

Based on the AJCC (American Joint Committee on Cancer) staging system for breast cancer:

- **Stage I**: Typically involves T1 tumors with no lymph node involvement (N0).
- **Stage II**: Includes T2 tumors with N0 or N1 lymph node involvement.
- **Stage III**: Generally involves larger tumors (T3 or T4) or more extensive lymph node involvement (N2 or N3).
- **Stage IV**: Indicates the presence of distant metastasis (M1).

Given the T2 classification, N1 lymph node involvement, and no confirmed distant metastasis (pMX), the cancer is best classified as Stage II.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
12,"## Answer
The pathology report provides the following information:

1. **Tumor Size and Classification**: The report mentions two tumor sizes: 2.5 cm and 0.7 cm. The classification is pT2(mult), which indicates multiple tumors with the largest being greater than 2 cm but not more than 5 cm.

2. **Lymph Node Involvement**: The classification NO(sn) indicates that there is no regional lymph node metastasis (N0).

3. **Distant Metastasis**: The report does not mention any distant metastasis, which is indicated by M0 (though not explicitly stated, the absence of M1 suggests no metastasis).

4. **Overall Tumor Grade**: The tumor is poorly differentiated, which is Grade III.

According to the AJCC (American Joint Committee on Cancer) staging system:

- **Stage I**: Typically involves T1 (tumor ≤ 2 cm) and N0, M0.
- **Stage II**: Involves T2 (tumor > 2 cm but ≤ 5 cm) and N0, M0.
- **Stage III**: Generally involves larger tumors or regional lymph node involvement.
- **Stage IV**: Involves distant metastasis (M1).

Given the information:
- The largest tumor is 2.5 cm, which fits the T2 category.
- There is no lymph node involvement (N0).
- There is no mention of distant metastasis (M0).

Therefore, the cancer fits the criteria for Stage II, as it is a T2 tumor with no lymph node involvement and no distant metastasis.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
13,"## Answer
To determine the AJCC stage of the cancer, we need to consider the TNM classification provided in the pathology report:

1. **Tumor Size (T):** The report states ""PTNM stage: T2N1MX."" The ""T2"" classification indicates that the primary tumor is more than 2 cm but not more than 5 cm in greatest dimension. In this case, the tumor size is 2.5 x 2 x 1.8 cm, which fits the T2 category.

2. **Lymph Node Involvement (N):** The ""N1"" classification indicates that there is metastasis to 1-3 axillary lymph nodes. The report confirms this with ""Sentinel, 1/2; Level 1 and II, 1/8,"" indicating that there are metastatic carcinoma cells in 2 lymph nodes.

3. **Distant Metastasis (M):** The ""MX"" classification means that the presence of distant metastasis cannot be assessed. However, for staging purposes, if distant metastasis is not confirmed, it is typically considered as M0 (no distant metastasis).

Based on the TNM classification of T2N1M0, we can determine the AJCC stage:

- **Stage I:** Typically corresponds to T1N0M0.
- **Stage II:** Can correspond to T2N0M0 or T1N1M0.
- **Stage III:** Can correspond to T2N1M0, T3N0M0, or other combinations with higher N classifications.
- **Stage IV:** Involves any T, any N, and M1 (confirmed distant metastasis).

Given the classification of T2N1M0, the cancer is classified as Stage II.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
14,"## Answer
The pathology report provides the following key information for staging:

1. **Primary Tumor (T):** The tumor is described as pT2, which indicates a tumor size greater than 2.0 cm but not more than 5.0 cm.

2. **Regional Lymph Nodes (N):** The report states pN1a, which means there is metastasis in 1 to 3 axillary lymph nodes, with at least one tumor deposit greater than 2.0 mm. In this case, 2 out of 13 lymph nodes are involved.

3. **Distant Metastasis (M):** The report indicates pMX, meaning distant metastasis cannot be assessed.

According to the AJCC (American Joint Committee on Cancer) staging system for breast cancer:

- **Stage I** typically involves T1 (tumor ≤ 2 cm) and N0 (no regional lymph node involvement).
- **Stage II** can involve T2 with N0 or N1 (1-3 lymph nodes involved).
- **Stage III** involves more extensive lymph node involvement (N2 or N3) or larger tumors (T3 or T4).
- **Stage IV** involves distant metastasis (M1).

Given the information:
- The tumor size is T2.
- There is limited lymph node involvement (N1a).
- Distant metastasis cannot be assessed (MX).

This aligns with **Stage II** breast cancer, as it involves a T2 tumor with N1 lymph node involvement and no confirmed distant metastasis.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
15,"## Answer
To determine the AJCC stage of the cancer, we need to consider the tumor size, lymph node involvement, and presence of metastasis.

1. **Tumor Size (T):** The pathology report states ""Infiltrating ductal carcinoma... forming a mass (2.2 x 1.6 x 1.6 cm)"" and specifies ""[AJCC pT2]"". According to AJCC staging, a pT2 tumor is greater than 2 cm but not more than 5 cm in greatest dimension.

2. **Lymph Node Involvement (N):** The report mentions ""Multiple (5) right axillary sentinel lymph nodes are negative for metastatic carcinoma [AJCC pNO (i-) (sn)]"". This indicates that there is no regional lymph node metastasis, which corresponds to N0.

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, so we assume M0.

Combining these factors:
- T2 (tumor size > 2 cm but ≤ 5 cm)
- N0 (no regional lymph node metastasis)
- M0 (no distant metastasis)

According to the AJCC 8th Edition Cancer Staging Manual for breast cancer, a T2 N0 M0 classification corresponds to Stage II.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
16,"## Answer
To determine the AJCC stage of the cancer from the pathology report, we need to consider the tumor size, lymph node involvement, and presence of metastasis.

1. **Tumor Size (T):** The report states the tumor size is 1.3 by 1.2 by 1.0 cm. According to AJCC staging, a tumor size of 2 cm or less is classified as T1.

2. **Lymph Node Involvement (N):** The report indicates that one out of twenty-three right axillary lymph nodes has metastatic carcinoma with extracapsular extension. This suggests lymph node involvement. According to AJCC staging, involvement of 1-3 axillary lymph nodes is classified as N1.

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, so we assume M0.

Based on the above information:
- T1 (tumor size ≤ 2 cm)
- N1 (1-3 lymph nodes involved)
- M0 (no distant metastasis)

According to the AJCC staging system, a combination of T1, N1, and M0 corresponds to Stage IIA breast cancer. However, the options provided do not include Stage IIA specifically, but Stage II generally encompasses T1N1M0.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
17,"## Answer
The pathology report provides the following key information for staging the breast cancer according to the AJCC (American Joint Committee on Cancer) guidelines:

1. **Tumor Size (T):** The invasive lobular carcinoma is 3.0 cm in greatest dimension. According to the AJCC, a tumor size of more than 2 cm but not more than 5 cm is classified as T2.

2. **Lymph Node Involvement (N):** The report indicates that there are 3 lymph nodes examined, with 1 node showing macrometastasis (9 mm) and 1 node showing micrometastasis (1 mm). This corresponds to N1a, which indicates metastasis in 1-3 axillary lymph nodes.

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, which implies M0.

Combining these, the TNM classification is pT2 N1a M0. According to the AJCC 8th edition staging system for breast cancer, this corresponds to Stage IIB.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
18,"## Answer
The pathology report provides the following key information:

1. **Tumor Size**: The tumor diameter is 9 cm.
2. **Tumor Grade**: The tumor is highly differentiated, which corresponds to Grade I.
3. **Tumor Classification**: The classification given is pT3N0M0.

According to the AJCC (American Joint Committee on Cancer) staging system for breast cancer:

- **T3** indicates a tumor size greater than 5 cm but not more than 10 cm.
- **N0** indicates no regional lymph node metastasis.
- **M0** indicates no distant metastasis.

Based on the AJCC staging system for breast cancer:

- **Stage I**: T1, N0, M0
- **Stage II**: T2, N0, M0 or T1, N1, M0
- **Stage III**: T3, N0, M0 or T2, N2, M0, etc.
- **Stage IV**: Any T, Any N, M1

Given the classification of pT3N0M0, this corresponds to Stage III breast cancer.

Therefore, the answer is - 
{""stage"" : ""Stage III""}"
19,"## Answer
The pathology report provides the following key information for staging:

1. **Tumor Size and Type**: The right breast has two tumors, both invasive lobular carcinoma, each measuring 1.0 cm in greatest dimension. The pathologic stage is noted as pT1c, which corresponds to a tumor size greater than 1 cm but not more than 2 cm.

2. **Lymph Node Involvement**: The report indicates that four out of four lymph nodes are positive for tumor involvement. Specifically, three sentinel lymph nodes and one non-sentinel lymph node in the right axilla are positive for carcinoma, with extracapsular extension noted in the non-sentinel node. This corresponds to N2, which indicates metastasis to 4-9 axillary lymph nodes.

3. **Distant Metastasis**: The report does not provide information on distant metastasis (MX), meaning it is not assessed.

Based on the AJCC 6th edition staging system:
- T1c indicates a tumor size greater than 1 cm but not more than 2 cm.
- N2 indicates metastasis to 4-9 axillary lymph nodes.
- MX indicates that distant metastasis has not been assessed.

Combining these, the cancer is staged as Stage IIIA, which corresponds to T1c N2 M0 (assuming no distant metastasis).

Therefore, the answer is - 
{""stage"" : ""Stage III""}"
20,"## Answer
The pathology report provides several key pieces of information necessary for staging the cancer according to the AJCC (American Joint Committee on Cancer) guidelines:

1. **Tumor Size (T):** The invasive ductal carcinoma measures 1.5 cm in greatest dimension. According to AJCC, a tumor size of 1.5 cm falls under T1 (specifically T1c, which is >1 cm but ≤2 cm).

2. **Lymph Node Involvement (N):** The report mentions a single keratin-positive cell suspicious for an isolated tumor cell in one lymph node, and no tumor present in another lymph node. This suggests N0(i+), which indicates isolated tumor cells in lymph nodes but not enough to be considered positive for metastasis.

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, so we assume M0.

Based on the above information:
- T1c (tumor size >1 cm but ≤2 cm)
- N0(i+) (isolated tumor cells in lymph nodes)
- M0 (no distant metastasis)

According to the AJCC 8th edition staging system, a T1c N0(i+) M0 breast cancer is classified as Stage I.

Therefore, the answer is - 
{""stage"" : ""Stage I""}"
21,"## Answer
To determine the AJCC stage of the cancer, we need to consider the tumor size, lymph node involvement, and presence of metastasis.

1. **Tumor Size (T):** The report describes three masses measuring 2.0 cm, 1.9 cm, and 1.1 cm. The largest tumor is 2.0 cm. According to AJCC, a tumor size of 2.0 cm falls under T1c (greater than 1 cm but not more than 2 cm).

2. **Lymph Node Involvement (N):** 
   - Metastatic adenocarcinoma is found in one of one sentinel lymph node, with a maximum size of metastasis of 0.3 cm.
   - Metastatic adenocarcinoma is also found in one of one palpable lymph node in the left axilla, with a maximum size of metastasis of 0.9 cm and extranodal extension present.
   - Additionally, metastatic adenocarcinoma is found in three of thirty-one lymph nodes in the left axillary contents, with a maximum size of metastasis of 0.4 cm and extranodal extension present.
   - This indicates significant lymph node involvement, which corresponds to N2 (metastasis in 4-9 axillary lymph nodes or in clinically apparent internal mammary lymph nodes in the absence of axillary lymph node metastasis).

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, so M0 is assumed.

Combining these factors:
- T1c (tumor size)
- N2 (lymph node involvement)
- M0 (no distant metastasis)

According to the AJCC staging system, T1c N2 M0 corresponds to Stage IIIA.

Therefore, the answer is - 
{""stage"" : ""Stage III""}"
22,"## Answer
To determine the AJCC stage of the cancer, we need to consider the T, N, and M stages provided in the pathology report:

1. **T Stage (Tumor Size/Extent):** The report states ""T Stage: 2"". According to the AJCC staging system, T2 indicates a tumor size greater than 2 cm but not more than 5 cm.

2. **N Stage (Regional Lymph Nodes):** The report states ""N Stage: 1"". N1 indicates that there is metastasis to movable ipsilateral axillary lymph nodes.

3. **M Stage (Distant Metastasis):** The report states ""M Stage: 0"". M0 indicates no distant metastasis.

Based on the AJCC staging system for breast cancer:
- **Stage I** typically involves T1, N0, M0.
- **Stage II** can involve T2, N0, M0 or T1-2, N1, M0.
- **Stage III** involves more advanced combinations such as T3 or N2.
- **Stage IV** involves any T, any N, and M1.

Given the T2, N1, M0 classification, this corresponds to Stage II breast cancer.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
23,"## Answer
To determine the AJCC stage of the cancer, we need to consider the tumor size, lymph node involvement, and metastasis status. The provided pathology report gives us the following information:

1. **Tumor Size**: The report mentions a white and firm area measuring 0.4 cm in the largest diameter. This indicates a small tumor size.

2. **Lymph Node Involvement**: The report does not mention any lymph node involvement. In the absence of information, we assume there is no lymph node involvement.

3. **Metastasis**: There is no mention of distant metastasis in the report.

4. **Histological Grade**: The tumor is described as invasive lobular carcinoma, grade 1, which is a low-grade tumor.

Based on the AJCC staging system for breast cancer:
- **Stage I** typically involves a tumor size of up to 2 cm with no lymph node involvement and no distant metastasis.
- **Stage II** involves larger tumors or limited lymph node involvement.
- **Stage III** involves more extensive lymph node involvement or larger tumors.
- **Stage IV** involves distant metastasis.

Given the small tumor size (0.4 cm), no lymph node involvement, and no distant metastasis, the cancer is consistent with Stage I.

Therefore, the answer is - 
{""stage"" : ""Stage I""}"
24,"## Answer
The pathology report provides the following key information for staging:

1. **Tumor Size (T):** The tumor is described as invasive mucinous carcinoma with a size of 2.5 cm. According to the AJCC staging system, a tumor size of more than 2 cm but not more than 5 cm is classified as T2.

2. **Lymph Node Involvement (N):** The report states ""There is no evidence of malignancy in either of 2 lymph nodes,"" which indicates N0 (no regional lymph node metastasis).

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, so we assume M0 (no distant metastasis).

Based on the TNM classification provided in the report (T2 N0 M0), we can determine the stage:

- **Stage I:** Typically involves T1 N0 M0.
- **Stage II:** Can involve T2 N0 M0.
- **Stage III:** Involves more extensive lymph node involvement or larger tumors.
- **Stage IV:** Involves distant metastasis.

Given the TNM classification of T2 N0 M0, the cancer is classified as Stage II.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
25,"## Answer
The pathology report provides the following key information for staging:

1. **Primary Tumor (pT):** The tumor is classified as pT3, which indicates a tumor greater than 50 mm in greatest dimension. In this case, the tumor is 7.0 cm (70 mm).

2. **Regional Lymph Nodes (pN):** The report states pN0, meaning no regional lymph node metastasis was identified histologically. Two sentinel lymph nodes were examined, and both were negative for malignancy.

3. **Distant Metastasis (pM):** The report indicates ""Not applicable"" for distant metastasis, which typically means there is no evidence of distant metastasis (pM0).

Based on the AJCC staging system for breast cancer:

- **Stage I** typically involves smaller tumors (≤2 cm) with no lymph node involvement.
- **Stage II** involves larger tumors (2-5 cm) or small tumors with limited lymph node involvement.
- **Stage III** involves larger tumors (>5 cm) or any size tumor with significant lymph node involvement.
- **Stage IV** involves any tumor size with distant metastasis.

Given the tumor size (pT3) and no lymph node involvement (pN0), the cancer is classified as Stage II. Stage III would require either lymph node involvement or a larger tumor with more extensive local spread, which is not the case here.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
26,"## Answer
To determine the AJCC stage of the cancer, we need to consider the tumor size, lymph node involvement, and presence of metastasis.

1. **Tumor Size (T):** The pathology report states ""Infiltrating lobular carcinoma... forming a 1.6 x 1.5 x 1.3 cm mass (AJCC pT1c)."" According to AJCC staging, a tumor size of more than 1 cm but not more than 2 cm is classified as T1c.

2. **Lymph Node Involvement (N):** The report mentions ""Lymph nodes, right sentinel, excision: Negative for tumor."" This indicates that there is no regional lymph node involvement, which corresponds to N0.

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, so we assume M0.

Based on the TNM classification:
- T1c (tumor size >1 cm but ≤2 cm)
- N0 (no regional lymph node involvement)
- M0 (no distant metastasis)

According to the AJCC staging system, a combination of T1c, N0, and M0 corresponds to Stage I.

Therefore, the answer is - 
{""stage"" : ""Stage I""}"
27,"## Answer
The pathology report provides the following key information:

1. **Tumor Size (T):** The tumor measures 3 cm in maximum dimension. According to the AJCC staging system, a tumor size of more than 2 cm but not more than 5 cm is classified as T2.

2. **Lymph Node Involvement (N):** There is one positive sentinel lymph node (1/1). This indicates N1, which means metastasis to 1 to 3 axillary lymph nodes.

3. **Distant Metastasis (M):** The report mentions MX, which means that distant metastasis cannot be assessed.

Based on the TNM classification provided in the report (T2 N1 MX), the AJCC stage is determined as Stage IIB. This is consistent with the information given in the report under the PTNM classification: Stage IIB.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
28,"## Answer
The pathology report provides several key pieces of information that are crucial for determining the AJCC stage of the cancer:

1. **Primary Tumor (T):** The invasive lobular carcinoma involves an area of approximately 8.5 cm in the lateral aspect of the left breast. This size suggests a T2 or T3 classification, depending on the specific criteria used (T2 is for tumors >2 cm but ≤5 cm, and T3 is for tumors >5 cm).

2. **Regional Lymph Nodes (N):** There is metastatic carcinoma in one sentinel lymph node and in nine of twenty-one axillary lymph nodes. The presence of metastasis in 10 lymph nodes (1 sentinel + 9 axillary) indicates an N2 or N3 classification. N2 is for metastasis in 4-9 axillary lymph nodes, and N3 is for metastasis in 10 or more axillary lymph nodes or in infraclavicular (level III axillary) lymph nodes.

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, which suggests M0.

Based on the information provided:
- The tumor size and lymph node involvement suggest a classification of at least T3N2 or T3N3.
- The absence of distant metastasis (M0) rules out Stage IV.

Given the significant lymph node involvement (10 nodes), the cancer is likely classified as Stage III, which corresponds to T3N2 or T3N3M0.

Therefore, the answer is - 
{""stage"" : ""Stage III""}"
29,"## Answer
To determine the AJCC stage of the cancer, we need to consider the tumor size, lymph node involvement, and presence of metastasis.

1. **Tumor Size (T):** The pathology report indicates the tumor is 1.3 x 1.3 x 1.2 cm, which corresponds to AJCC pT1c (tumor more than 1 cm but not more than 2 cm in greatest dimension).

2. **Lymph Node Involvement (N):** The report states that multiple (2) right axillary sentinel lymph nodes are negative for metastatic carcinoma, which corresponds to AJCC pN0 (no regional lymph node metastasis).

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, so we assume M0 (no distant metastasis).

Based on the AJCC 8th edition staging system for breast cancer:
- T1c
- N0
- M0

This combination corresponds to Stage I breast cancer.

Therefore, the answer is - 
{""stage"" : ""Stage I""}"
30,"## Answer
The pathology report provides the following key information for staging:

1. **Primary Tumor (T):** The tumor is described as an infiltrating ductal carcinoma, moderately differentiated, with a size of 2.0 cm in greatest dimension. According to the AJCC 8th edition, a tumor size of more than 1 cm but not more than 2 cm is classified as T1c.

2. **Regional Lymph Nodes (N):** The report indicates that no carcinoma was seen in any of the examined lymph nodes (0/11), and the pathologic staging is pN0, meaning no regional lymph node metastasis.

3. **Distant Metastasis (M):** The report states ""Mx,"" indicating that distant metastasis cannot be assessed, but there is no evidence provided of distant metastasis.

Based on the TNM classification:
- T1c: Tumor size more than 1 cm but not more than 2 cm.
- N0: No regional lymph node metastasis.
- Mx: Distant metastasis cannot be assessed, but no evidence of metastasis is provided.

Given these findings, the cancer is classified as Stage I according to the AJCC staging system, which corresponds to T1c N0 M0.

Therefore, the answer is - 
{""stage"" : ""Stage I""}"
31,"## Answer
To determine the AJCC stage of the cancer, we need to consider the tumor size, lymph node involvement, and presence of metastasis.

1. **Tumor Size (T):** The pathology report indicates a mass of size 9.2 x 4.2 x 3.2 cm, which corresponds to AJCC pT3. According to AJCC staging, T3 indicates a tumor larger than 5 cm.

2. **Lymph Node Involvement (N):** The report states that multiple (4) left axillary sentinel lymph nodes are negative for metastatic carcinoma, which corresponds to AJCC pN0. This means there is no regional lymph node involvement.

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, so we assume M0.

Based on the AJCC staging system:
- T3 N0 M0 corresponds to Stage IIB.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
32,"## Answer
To determine the AJCC stage of the cancer, we need to consider the tumor size, lymph node involvement, and presence of metastasis.

1. **Tumor Size (T):** The report states that the invasive ductal carcinoma is 3.5 cm in greatest dimension. According to the AJCC staging system, a tumor size of more than 2 cm but not more than 5 cm is classified as T2.

2. **Lymph Node Involvement (N):** The pathology report indicates metastatic carcinoma in 2 of 14 lymph nodes, with the largest metastasis being 3.4 cm and extracapsular extension present. This corresponds to N1, which is defined as metastasis in 1-3 axillary lymph nodes.

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, so we assume M0.

Based on the above information:
- T2 (tumor size 3.5 cm)
- N1 (metastasis in 2 lymph nodes)
- M0 (no distant metastasis)

According to the AJCC 8th edition staging system, a combination of T2, N1, and M0 corresponds to Stage IIB.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
33,"## Answer
To determine the AJCC stage of the cancer, we need to consider the tumor size, lymph node involvement, and presence of metastasis.

1. **Tumor Size (T):** The report indicates an invasive lobular carcinoma with a tumor size of 2.6 cm. According to the AJCC staging system, a tumor size greater than 2 cm but not more than 5 cm is classified as T2.

2. **Lymph Node Involvement (N):** The pathology report states that both sentinel lymph nodes (SLN #1 and SLN #2) are negative for carcinoma (0/1 for each). This indicates no regional lymph node involvement, which corresponds to N0.

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, so we assume M0.

Based on the TNM classification:
- T2 (tumor size > 2 cm but ≤ 5 cm)
- N0 (no regional lymph node involvement)
- M0 (no distant metastasis)

The combination of T2, N0, and M0 corresponds to Stage II according to the AJCC staging system for breast cancer.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
34,"## Answer
To determine the AJCC stage of the breast cancer from the pathology report, we need to consider the tumor size, lymph node involvement, and presence of metastasis.

1. **Tumor Size (T):** The tumor is described as 4.3 x 2.3 x 2.7 cm. According to the AJCC staging system, a tumor size greater than 2 cm but not more than 5 cm is classified as T2.

2. **Lymph Node Involvement (N):** The report indicates ""Metastases carcinomatosae in lymphonodis axillae (No II/XVII),"" meaning there are cancer metastases in 2 out of 17 axillary lymph nodes. This corresponds to N1, which is defined as metastasis in 1-3 axillary lymph nodes.

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, so we assume M0.

Combining these, we have:
- T2 (tumor size > 2 cm but ≤ 5 cm)
- N1 (metastasis in 1-3 axillary lymph nodes)
- M0 (no distant metastasis)

According to the AJCC 8th edition staging system for breast cancer, T2 N1 M0 corresponds to Stage IIB.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
35,"## Answer
The pathology report indicates the following key findings:

1. **Tumor Size and Characteristics**: The left breast has multicentric in situ and infiltrating lobular carcinoma. The invasive carcinoma spans a gross distance of 7.0 cm from medial to lateral in the superior central portion of the specimen, with a distinct and separate 1.0 cm nodule of invasive lobular carcinoma in the upper outer quadrant. The tumor is nuclear grade II/III with a low mitotic index.

2. **Lymph Node Involvement**: Multiple sentinel lymph nodes from both the left and right axillary regions were biopsied. All lymph nodes show no evidence of metastatic disease, supported by negative cytokeratin immunohistochemical staining.

3. **Margins**: The superficial and deep margins are free of tumor by at least 1 cm.

4. **Contralateral Breast**: The right breast shows fibrocystic changes with no evidence of malignancy.

Based on the AJCC staging system for breast cancer:
- **T (Tumor size)**: The primary tumor is greater than 5 cm (7.0 cm), which corresponds to T2 or T3 depending on other factors.
- **N (Node involvement)**: N0, as there is no regional lymph node metastasis.
- **M (Metastasis)**: M0, as there is no distant metastasis.

Given the tumor size and the absence of lymph node involvement or distant metastasis, the cancer is likely to be classified as Stage II. Stage I would typically involve smaller tumors (≤2 cm) with no lymph node involvement, while Stage III would involve larger tumors with lymph node involvement or other local spread, and Stage IV would involve distant metastasis.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
36,"## Answer
The pathology report provides the following key information for staging:

1. **Primary Tumor (T):** The tumor is described as invasive ductal carcinoma, poorly differentiated, with a size of 2.8 cm in greatest dimension. According to the AJCC staging system, a tumor size greater than 2 cm but less than or equal to 5 cm is classified as T2.

2. **Regional Lymph Nodes (N):** The report indicates that no malignancy was seen in any of the sentinel lymph nodes examined (0/6), and the pathologic staging is noted as pN0, meaning no regional lymph node metastasis.

3. **Distant Metastasis (M):** The report does not provide information on distant metastasis, and it is marked as MX, which means distant metastasis cannot be assessed.

Based on the provided information:
- The tumor size classifies it as T2.
- The absence of lymph node involvement classifies it as N0.
- The distant metastasis status is MX, but since there is no evidence of distant metastasis provided, we assume M0 for staging purposes.

According to the AJCC staging system for breast cancer:
- T2 N0 M0 corresponds to Stage II.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
37,"## Answer
The pathology report describes a case of infiltrating lobular carcinoma in the left breast with lobular carcinoma in situ and atypical lobular hyperplasia. The tumor is 3.2 x 3.0 x 2.0 cm in size and is located 0.3 cm from the posterior margin. There is no mention of lymph node involvement or distant metastasis in the report. 

According to the AJCC (American Joint Committee on Cancer) staging system for breast cancer, the staging is primarily based on the size of the tumor (T), the involvement of lymph nodes (N), and the presence of distant metastasis (M).

- **Tumor size (T):** The tumor is 3.2 cm, which corresponds to T2 (tumor more than 2 cm but not more than 5 cm in greatest dimension).
- **Lymph nodes (N):** The report does not mention lymph node involvement, which suggests N0 (no regional lymph node metastasis).
- **Metastasis (M):** There is no mention of distant metastasis, suggesting M0 (no distant metastasis).

Based on the information provided:
- T2 N0 M0 corresponds to Stage II according to the AJCC staging system.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
38,"## Answer
To determine the AJCC stage of the cancer, we need to consider the tumor size, lymph node involvement, and presence of metastasis.

1. **Tumor Size (T):** The tumor size is given as 2.4 x 0 x 2.8 cm. For breast cancer staging, the T category is based on the largest dimension. Here, the largest dimension is 2.8 cm. According to AJCC 8th edition, a tumor size of 2.8 cm falls into the T2 category (tumors >2 cm but ≤5 cm).

2. **Lymph Node Involvement (N):** The report indicates 1 out of 10 axillary lymph nodes is positive for metastasis. This corresponds to N1, which is defined as metastasis to 1-3 axillary lymph nodes.

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, so we assume M0 (no distant metastasis).

Based on the above information:
- T2 (tumor size >2 cm but ≤5 cm)
- N1 (metastasis to 1-3 axillary lymph nodes)
- M0 (no distant metastasis)

According to the AJCC 8th edition staging system for breast cancer, a combination of T2, N1, and M0 corresponds to Stage IIB.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
39,"## Answer
The pathology report provides the following information:

- **T Stage**: 2
- **N Stage**: 0
- **M Stage**: 0

According to the AJCC (American Joint Committee on Cancer) staging system for breast cancer:

- **T2** indicates a tumor size greater than 2 cm but not more than 5 cm.
- **N0** indicates no regional lymph node involvement.
- **M0** indicates no distant metastasis.

The combination of T2, N0, and M0 corresponds to Stage II breast cancer.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
40,"## Answer
To determine the AJCC stage of the cancer, we need to consider the tumor size, lymph node involvement, and presence of metastasis.

1. **Tumor Size (T):** The tumor is described as 3.3 x 1.8 x 3.2 cm. According to the AJCC staging system, a tumor size greater than 2 cm but not more than 5 cm is classified as T2.

2. **Lymph Node Involvement (N):** The report indicates ""Metastases carcinomatosae in lymphonodis axillae (NO III/XVI)"" which means there are cancer metastases in 3 out of 16 axillary lymph nodes. This corresponds to N1a, which indicates metastasis in 1-3 axillary lymph nodes.

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, so we assume M0.

Based on the TNM classification:
- T2 (tumor size > 2 cm but ≤ 5 cm)
- N1a (metastasis in 1-3 axillary lymph nodes)
- M0 (no distant metastasis)

According to the AJCC 8th edition staging system for breast cancer:
- T2 N1 M0 corresponds to Stage IIB.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
41,"## Answer
To determine the AJCC stage of the cancer, we need to consider the tumor size, lymph node involvement, and any distant metastasis.

1. **Tumor Size (T):** The report states the tumor is 2.8 x 2.6 cm, which corresponds to T2 (tumor size more than 2 cm but not more than 5 cm).

2. **Lymph Node Involvement (N):** The report indicates that 0 out of 10 lymph nodes are positive for metastasis. This corresponds to N0 (no regional lymph node metastasis).

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, so we assume M0 (no distant metastasis).

Based on the TNM classification:
- T2
- N0
- M0

According to the AJCC staging system for breast cancer:
- T2 N0 M0 corresponds to Stage II.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
42,"## Answer
To determine the AJCC stage of the cancer, we need to consider several factors from the pathology report, including tumor size, lymph node involvement, and metastasis.

1. **Tumor Size (T):** The macroscopic description indicates a surgical specimen size of 5 x 4 x 2 cm. The minimum side margin is 0.2 cm. This suggests the tumor is relatively small, likely corresponding to T1 or T2 in the AJCC staging system, depending on the exact measurement criteria.

2. **Lymph Node Involvement (N):** The report does not mention any lymph node involvement. In the absence of lymph node involvement, we would consider N0.

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, which would suggest M0.

4. **Histological Grade and Other Factors:** The histopathological diagnosis is ""Carcinoma papillare probabiliter invasivum NHG1,"" which indicates a low-grade tumor (Grade 1). The presence of DCIS (ductal carcinoma in situ) without necrosis and low Ki67 proliferation index (5%) also suggests a less aggressive tumor.

5. **Receptor Status:** The tumor is hormone receptor-positive (estrogen and progesterone receptors found in over 75% of cells) and HER2-negative, which typically indicates a better prognosis.

Based on the information provided, the tumor is likely small (T1 or T2), with no lymph node involvement (N0), and no distant metastasis (M0). This would correspond to an early-stage breast cancer, likely Stage I.

Therefore, the answer is - 
{""stage"" : ""Stage I""}"
43,"## Answer
The pathology report provides the following key information for staging:

1. **Tumor Size and Extent (T)**: The largest invasive ductal carcinoma (IDC) focus is 4.0 cm, which corresponds to T2 (tumor size >2 cm but ≤5 cm).

2. **Lymph Node Involvement (N)**: The report indicates that 2 out of 16 axillary lymph nodes are positive for metastatic carcinoma, with the largest metastasis being 0.8 cm and no extracapsular extension. This corresponds to N1a (metastasis in 1-3 axillary lymph nodes).

3. **Distant Metastasis (M)**: There is no mention of distant metastasis in the report, so we assume M0 (no distant metastasis).

Based on the TNM classification provided in the report (pT2 pN1a), we can determine the AJCC stage:

- **Stage I**: Typically involves T1 or T2 with N0.
- **Stage II**: Involves T2 with N1 or T3 with N0.
- **Stage III**: Involves T0-T3 with N2 or T4 with any N.
- **Stage IV**: Involves any T, any N with M1.

Given the classification pT2 pN1a M0, this corresponds to Stage II.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
44,"## Answer
The pathology report provides the following key information for staging:

1. **Tumor Size**: The tumor is 3.5 cm in greatest dimension. According to the AJCC staging system, a tumor size greater than 2 cm but not more than 5 cm is classified as T2.

2. **Lymph Node Involvement**: The report states that ten lymph nodes were examined and all were negative for tumor involvement. This corresponds to N0, indicating no regional lymph node metastasis.

3. **Distant Metastasis**: The report does not provide information on distant metastasis (MX), but for the purpose of staging based on available data, we assume M0 (no distant metastasis).

Based on the above information, the pathologic stage is pT2 N0 M0. According to the AJCC 8th Edition Cancer Staging Manual, this corresponds to Stage II.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
45,"## Answer
The pathology report provides the following key information for staging:

1. **Tumor Size (T):** The invasive component of the tumor is 2.0 cm, which corresponds to T1c (tumor more than 1 cm but not more than 2 cm in greatest dimension).

2. **Lymph Node Involvement (N):** There is metastatic adenocarcinoma in one of three sentinel lymph nodes, with a metastasis size of 5 millimeters and no extranodal invasion. This corresponds to N1a (metastasis in 1-3 axillary lymph nodes).

3. **Distant Metastasis (M):** The report states pMX, indicating that distant metastasis cannot be assessed from the current specimen.

Based on the AJCC staging system, the combination of T1c, N1a, and MX typically corresponds to Stage II cancer. Stage I would require no lymph node involvement (N0), and Stage III would require more extensive lymph node involvement or a larger tumor size. Stage IV would require confirmed distant metastasis, which is not indicated here.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
46,"## Answer
The pathology report provides detailed information about the breast cancer diagnosis and staging. Let's break down the key elements:

1. **Tumor Size (T):** The invasive ductal carcinoma measures 5.0 cm in largest dimension. According to the AJCC staging system, a tumor size greater than 2 cm but not more than 5 cm is classified as T2.

2. **Lymph Node Involvement (N):** The report indicates metastatic carcinoma in lymph nodes, specifically:
   - Sentinel node #1: Metastatic carcinoma with extranodal extension.
   - Sentinel node #2: Metastatic carcinoma without extranodal extension.
   - Sentinel node #3: Benign.
   - Levels I and II: Micrometastatic carcinoma in one out of eighteen lymph nodes.
   - Overall, 3 out of 26 lymph nodes are positive for cancer.
   - This corresponds to pN1a, which indicates metastasis in 1-3 axillary lymph nodes.

3. **Distant Metastasis (M):** The report states MX, meaning distant metastasis cannot be assessed. However, there is no indication of distant metastasis in the report.

4. **Stage Grouping:** The report explicitly mentions ""STAGE GROUPING IIB."" According to the AJCC staging system, Stage IIB corresponds to T2, N1, M0.

Therefore, based on the tumor size, lymph node involvement, and absence of distant metastasis, the cancer is classified as Stage IIB.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
47,"## Answer
To determine the AJCC stage of the breast cancer from the pathology report, we need to consider the tumor size, lymph node involvement, and any distant metastasis.

1. **Tumor Size (T):** The report indicates an invasive carcinoma with a gross tumor size of 2.4 x 2.4 x 1.5 cm. This corresponds to T2, as the tumor is greater than 2 cm but not more than 5 cm in greatest dimension.

2. **Lymph Node Involvement (N):** The report states that there is metastatic adenocarcinoma in two of fourteen axillary lymph nodes (2/14). This corresponds to N1, which indicates metastasis in 1-3 axillary lymph nodes.

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, so we assume M0.

Based on the TNM classification:
- T2 (tumor size > 2 cm but ≤ 5 cm)
- N1 (metastasis in 1-3 axillary lymph nodes)
- M0 (no distant metastasis)

According to the AJCC 8th edition staging system for breast cancer, a T2 N1 M0 classification corresponds to Stage IIB.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
48,"## Answer
The pathology report provides the following key information:

1. **Tumor Size**: The tumor measures 2.4 x 2.4 x 2.4 cm. According to the AJCC staging system, a tumor size of 2 cm to 5 cm typically corresponds to T2.

2. **Lymph Node Involvement**: The report states 0 out of 10 lymph nodes are positive for metastasis, indicating N0 (no regional lymph node involvement).

3. **Distant Metastasis**: There is no mention of distant metastasis, which suggests M0.

Based on the TNM classification:
- T2 (tumor size between 2 cm and 5 cm)
- N0 (no regional lymph node involvement)
- M0 (no distant metastasis)

According to the AJCC staging system for breast cancer:
- T2, N0, M0 corresponds to Stage IIA.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
49,"## Answer
The pathology report provides the following key information:

1. **Tumor Size**: The invasive ductal carcinoma measures 1.5x1.5x1.2 cm.
2. **Lymph Node Involvement**: Both sentinel lymph nodes are negative for tumor (0/2).
3. **Margins**: The margins of resection are free of tumor.
4. **Invasion**: There is no vascular or lymphatic invasion.
5. **Pathologic Stage**: The report mentions a pathologic stage of pT1c.

According to the AJCC (American Joint Committee on Cancer) staging system for breast cancer:
- **T1c** indicates a tumor size greater than 1 cm but not more than 2 cm.
- **N0** indicates no regional lymph node metastasis.
- **M0** is assumed as there is no mention of distant metastasis.

Based on the above information, the cancer is classified as Stage I, which corresponds to T1c N0 M0.

Therefore, the answer is - 
{""stage"" : ""Stage I""}"
50,"## Answer
To determine the AJCC stage of the cancer, we need to consider the tumor size, lymph node involvement, and presence of metastasis.

1. **Tumor Size (T):** The report indicates an infiltrating moderately differentiated ductal carcinoma with a size of 2.5 by 2.0 by 1.5 cm. According to AJCC staging, a tumor size greater than 2 cm but not more than 5 cm is classified as T2.

2. **Lymph Node Involvement (N):** The report mentions micrometastatic ductal carcinoma in the right sentinel lymph node. Micrometastasis in lymph nodes is typically classified as N1mi (micrometastasis).

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, so we assume M0.

Based on the above information:
- T2 (tumor size > 2 cm but ≤ 5 cm)
- N1mi (micrometastasis in lymph nodes)
- M0 (no distant metastasis)

According to the AJCC 8th edition staging system for breast cancer, a T2 N1mi M0 classification corresponds to Stage IIA.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
51,"## Answer
To determine the AJCC stage of the cancer, we need to consider the tumor size, lymph node involvement, and presence of metastasis.

1. **Tumor Size (T):** The pathology report states that the tumor is 2.0 x 1.8 x 1.5 cm, which corresponds to pT1c. According to AJCC, pT1c is for tumors more than 1 cm but not more than 2 cm in greatest dimension.

2. **Lymph Node Involvement (N):** The report indicates that there is a single axillary sentinel lymph node positive for isolated tumor cell clusters, measuring 0.11 mm, classified as pN0(i+). This means there are isolated tumor cells in the lymph node, but they are not considered significant enough to classify as pN1, which would indicate more extensive lymph node involvement.

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, so we assume M0.

Based on the AJCC 8th edition staging system for breast cancer:
- **Stage I** includes T1 (tumor ≤ 2 cm) with N0 or N0(i+) and M0.
- **Stage II** typically involves larger tumors or more significant lymph node involvement.
- **Stage III** involves even larger tumors or more extensive lymph node involvement.
- **Stage IV** involves distant metastasis.

Given the tumor size (T1c), isolated tumor cells in a lymph node (N0(i+)), and no distant metastasis (M0), the cancer is classified as Stage I.

Therefore, the answer is - 
{""stage"" : ""Stage I""}"
52,"## Answer
The pathology report provides the following key information for staging:

1. **Tumor Size (T):** The invasive ductal carcinoma measures 1.2 cm. According to the AJCC Cancer Staging Manual, a tumor size of 1.2 cm corresponds to T1c (greater than 1 cm but not more than 2 cm).

2. **Lymph Node Involvement (N):** The sentinel lymph node biopsy is negative for metastases (0/1), indicating N0 (no regional lymph node metastasis).

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, which implies M0 (no distant metastasis).

Based on the TNM classification:
- T1c
- N0
- M0

According to the AJCC 7th Edition staging system, this corresponds to Stage I breast cancer.

Therefore, the answer is - 
{""stage"" : ""Stage I""}"
53,"## Answer
The pathology report provides detailed information about the patient's breast cancer diagnosis. Let's break down the key elements relevant to staging:

1. **Tumor Size (T):** The invasive ductal carcinoma measures 3.5 cm in greatest dimension. According to the AJCC staging system, a tumor size greater than 2 cm but not more than 5 cm is classified as T2.

2. **Lymph Node Involvement (N):** The report indicates that all sentinel lymph nodes (0/5) are negative for tumor cells, which corresponds to N0 (no regional lymph node metastasis).

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, which implies M0 (no distant metastasis).

Based on the TNM classification:
- T2 (tumor size >2 cm but ≤5 cm)
- N0 (no regional lymph node metastasis)
- M0 (no distant metastasis)

The combination of T2, N0, and M0 corresponds to Stage II breast cancer according to the AJCC staging system.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
54,"## Answer
To determine the AJCC stage of the breast cancer from the pathology report, we need to consider the tumor size, lymph node involvement, and presence of metastasis.

1. **Tumor Size (T):** The report states that the tumor is a poorly differentiated infiltrating duct carcinoma with a maximum microscopic dimension of 22 mm (2.2 cm). According to AJCC staging, a tumor size of 2 cm to 5 cm is classified as T2.

2. **Lymph Node Involvement (N):** The report mentions that three sentinel lymph nodes were examined (Parts B, C, and D), and there was no evidence of metastatic disease in any of them. This indicates N0, meaning no regional lymph node metastasis.

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, so we assume M0, meaning no distant metastasis.

Based on the above information:
- T2 (tumor size between 2 cm and 5 cm)
- N0 (no regional lymph node involvement)
- M0 (no distant metastasis)

According to the AJCC 8th edition staging system for breast cancer, a T2 N0 M0 classification corresponds to Stage II.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
55,"## Answer
The pathology report indicates the following key findings for staging:

1. **Tumor Size**: The invasive ductal carcinoma in the right breast is 2.5 cm in greatest dimension.
2. **Lymph Node Involvement**: Both sentinel lymph nodes examined are benign and negative for malignancy, indicating no regional lymph node involvement.
3. **Distant Metastasis**: There is no mention of distant metastasis in the report.

According to the AJCC (American Joint Committee on Cancer) staging system for breast cancer:
- **T2**: Tumor size is greater than 2 cm but not more than 5 cm.
- **N0**: No regional lymph node metastasis.
- **M0**: No distant metastasis.

Based on these findings, the cancer would be classified as T2N0M0, which corresponds to Stage II.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
56,"## Answer
To determine the AJCC stage of the cancer, we need to consider the tumor size, lymph node involvement, and presence of metastasis.

1. **Tumor Size (T):** The report states that the invasive ductal carcinoma is 3.0 cm in greatest dimension. According to AJCC staging, a tumor size of 2-5 cm is classified as T2.

2. **Lymph Node Involvement (N):** The report indicates that there are two negative sentinel lymph nodes and two additional negative lymph nodes, totaling 0/4 lymph nodes involved. This corresponds to N0, meaning no regional lymph node metastasis.

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, so we assume M0.

Based on the above information:
- T2 (tumor size 2-5 cm)
- N0 (no regional lymph node involvement)
- M0 (no distant metastasis)

According to the AJCC 8th edition staging system for breast cancer, a T2 N0 M0 classification corresponds to Stage II.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
57,"## Answer
The pathology report provides the following key information:

1. **Tumor Size and Type**: The invasive component of the tumor is 1.6 cm, which classifies it as T1c (tumor size >1 cm but ≤2 cm). The tumor is identified as invasive ductal carcinoma, apocrine type, with a nuclear grade of III of III.

2. **Lymph Node Involvement**: All lymph nodes sampled (14 in total) are negative for cancer, which classifies the nodal involvement as pN0.

3. **Metastasis**: There is no mention of distant metastasis, and the clinical stage is noted as cM0, indicating no clinical evidence of metastasis.

4. **AJCC Staging**: The report explicitly states ""AJCC CATEGORIES: Stage I (assuming 'cM0' status)"" and provides a pTNM classification of pT1c, pN0, cM0.

Based on the AJCC staging system, Stage I breast cancer is characterized by a tumor size of up to 2 cm (T1), no regional lymph node involvement (N0), and no distant metastasis (M0). The information provided in the report aligns with these criteria.

Therefore, the answer is - 
{""stage"" : ""Stage I""}"
58,"## Answer
The pathology report provides several key pieces of information that are crucial for determining the AJCC stage of the cancer:

1. **Tumor Size and Extent (T Stage):** The tumor measures 6.0 x 5.5 x 2.5 cm, and it is described as multicentric, involving multiple quadrants of the breast. The pathologic T stage is given as pT3, which indicates a tumor larger than 5 cm.

2. **Lymph Node Involvement (N Stage):** The report indicates extensive lymph node involvement. Specifically, 27 out of 27 lymph nodes are positive for metastatic carcinoma, with extracapsular extension noted. This extensive lymph node involvement corresponds to at least N2 or N3 in the AJCC staging system.

3. **Distant Metastasis (M Stage):** There is no mention of distant metastasis in the report, which suggests M0.

Based on the information provided:
- The T stage is pT3 due to the size of the tumor.
- The N stage is likely N3 due to the extensive lymph node involvement (20/20 axillary nodes and 6/6 level 3 nodes positive).
- The M stage is M0 as there is no evidence of distant metastasis.

According to the AJCC staging system, a combination of T3, N3, and M0 corresponds to Stage III.

Therefore, the answer is - 
{""stage"" : ""Stage III""}"
59,"## Answer
To determine the AJCC stage of the cancer, we need to consider the tumor size, lymph node involvement, and presence of metastasis.

1. **Tumor Size (T):** The report indicates a tumor size of 5.5 cm, which corresponds to T3 (tumor more than 5 cm in greatest dimension).

2. **Lymph Node Involvement (N):** The report states that 0 out of 10 lymph nodes are positive for metastasis, indicating N0 (no regional lymph node metastasis).

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, so we assume M0 (no distant metastasis).

Based on the AJCC staging system:
- T3, N0, M0 corresponds to Stage IIB.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
60,"## Answer
To determine the AJCC stage of the cancer, we need to consider the tumor size, lymph node involvement, and presence of distant metastasis.

1. **Tumor Size (T):** The pathology report states that the tumor measures 2.8 cm, which corresponds to pT2. According to AJCC staging, T2 indicates a tumor size greater than 2 cm but not more than 5 cm.

2. **Lymph Node Involvement (N):** The report indicates that the single lymph node examined is negative for metastatic disease, which corresponds to pN0.

3. **Distant Metastasis (M):** The report states that distant metastasis cannot be assessed (pM0 or pMX), but there is no indication of distant metastasis being present.

Based on the above information:
- T2 (tumor size 2.8 cm)
- N0 (no regional lymph node metastasis)
- M0 (no distant metastasis)

According to the AJCC staging system for breast cancer:
- T2, N0, M0 corresponds to Stage II.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
61,"## Answer
To determine the AJCC stage of the cancer, we need to consider the tumor size, lymph node involvement, and presence of metastasis.

1. **Tumor Size (T):** The pathology report states ""Medullary carcinoma forming a 4.5 x 2.0 x 2.0 cm well-circumscribed mass"" and specifies ""AJCC pT2"". According to AJCC staging, T2 indicates a tumor size greater than 2 cm but not more than 5 cm.

2. **Lymph Node Involvement (N):** The report mentions ""Multiple (5) left axillary sentinel lymph nodes are negative for tumor"" and specifies ""AJCC pN0(i-)"". This indicates that there is no regional lymph node metastasis.

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, which implies M0 (no distant metastasis).

Based on the above information:
- T2 (tumor size > 2 cm but ≤ 5 cm)
- N0 (no regional lymph node involvement)
- M0 (no distant metastasis)

According to the AJCC staging system for breast cancer:
- Stage I: T1, N0, M0
- Stage II: T2, N0, M0 or T1, N1, M0
- Stage III: T3, N0, M0 or T2, N1, M0, etc.
- Stage IV: Any T, Any N, M1

The combination of T2, N0, M0 corresponds to Stage II.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
62,"## Answer
The pathology report provides the following key information for staging:

1. **Primary Tumor (T):** The tumor is classified as pT4b, which indicates that the invasive carcinoma has direct extension to the skin with ulceration. According to the AJCC staging system, T4b is indicative of advanced local disease.

2. **Regional Lymph Nodes (N):** The report states pN0, meaning no regional lymph node metastasis was identified histologically. This suggests that the cancer has not spread to the lymph nodes.

3. **Distant Metastasis (M):** The report does not mention any distant metastasis, which is typically classified as M0 when no distant spread is identified.

Based on the AJCC staging system, a T4b classification with N0 and no distant metastasis (M0) corresponds to Stage III breast cancer. Stage IV would require evidence of distant metastasis, which is not present in this case.

Therefore, the answer is - 
{""stage"" : ""Stage III""}"
63,"## Answer
The pathology report provides the following key information for staging:

1. **Primary Tumor (pT):** The tumor is classified as pT2, which indicates a tumor size greater than 20 mm but less than 50 mm in greatest dimension.

2. **Regional Lymph Nodes (pN):** The report states pN0, meaning no regional lymph node metastasis is identified histologically. The sentinel lymph nodes examined were negative for carcinoma.

3. **Distant Metastasis (pM):** The report indicates ""Not applicable"" for distant metastasis, which implies there is no evidence of distant metastasis.

Based on the AJCC staging system:

- **Stage I** typically involves smaller tumors (pT1) and no lymph node involvement (pN0).
- **Stage II** can include larger tumors (pT2) with no lymph node involvement (pN0) or smaller tumors with limited lymph node involvement.
- **Stage III** generally involves more extensive lymph node involvement or larger tumors.
- **Stage IV** involves distant metastasis.

Given the tumor size (pT2) and no lymph node involvement (pN0), with no distant metastasis, the cancer is classified as Stage II.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
64,"## Answer
To determine the AJCC stage of the cancer, we need to consider the tumor size, lymph node involvement, and presence of metastasis.

1. **Tumor Size (T):** The report indicates a tumor size of 4 x 6 x 7 cm. According to the AJCC staging system, a tumor larger than 5 cm but not more than 7 cm is classified as T3.

2. **Lymph Node Involvement (N):** The report states that metastatic carcinoma is present in 3 lymph nodes (2 sentinel nodes and 1 of 9 axillary lymph nodes). This corresponds to N1a, which indicates metastasis in 1-3 axillary lymph nodes.

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, so we assume M0.

Based on the TNM classification:
- T3 (tumor size > 5 cm but ≤ 7 cm)
- N1a (metastasis in 1-3 axillary lymph nodes)
- M0 (no distant metastasis)

According to the AJCC 8th edition staging system for breast cancer, a T3 N1 M0 classification corresponds to Stage IIIA.

Therefore, the answer is - 
{""stage"" : ""Stage III""}"
65,"## Answer
The pathology report provides detailed information about the breast cancer diagnosis, including tumor size, lymph node involvement, and other relevant factors for staging according to the AJCC Cancer Staging Manual.

1. **Tumor Size (T):** The largest invasive tumor is 2.9 cm, which corresponds to T2 (tumor more than 2 cm but not more than 5 cm in greatest dimension).

2. **Lymph Node Involvement (N):** The report indicates metastatic carcinoma in 25 out of 36 lymph nodes, with extranodal extension. This corresponds to N3 (metastasis in 10 or more axillary lymph nodes, or in infraclavicular lymph nodes, or clinically apparent ipsilateral internal mammary lymph nodes in the presence of one or more positive axillary lymph nodes, or in more than 3 axillary lymph nodes and in internal mammary lymph nodes with microscopic disease detected by sentinel lymph node dissection but not clinically apparent).

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, so it is assumed to be M0.

Based on the AJCC 7th Edition criteria:
- T2
- N3
- M0

This combination of T2, N3, and M0 corresponds to Stage III breast cancer.

Therefore, the answer is - 
{""stage"" : ""Stage III""}"
66,"## Answer
To determine the AJCC stage of the cancer, we need to consider the tumor size, lymph node involvement, and presence of metastasis.

1. **Tumor Size (T):** The report indicates an invasive ductal carcinoma measuring 6 cm in the largest dimension. According to AJCC staging, a tumor greater than 5 cm but not more than 7 cm is classified as T2.

2. **Lymph Node Involvement (N):** The report shows that 2 out of 4 lymph nodes are positive for metastatic carcinoma, with no extranodal extension. This corresponds to N1, which indicates metastasis in 1-3 axillary lymph nodes.

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, so we assume M0.

Based on the above information:
- T2 (tumor size > 5 cm but ≤ 7 cm)
- N1 (metastasis in 1-3 axillary lymph nodes)
- M0 (no distant metastasis)

According to the AJCC 8th edition staging system for breast cancer, a T2 N1 M0 classification corresponds to Stage IIB.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
67,"## Answer
The pathology report provides the following key information:

1. **Tumor Size and Type**: The tumor is an infiltrating ductal carcinoma, grade III, with a size of 2.5 x 2.5 x 2 cm. According to the AJCC staging system, a tumor size greater than 2 cm but not more than 5 cm is classified as T2.

2. **Lymph Node Involvement**: The report states that multiple (3) right sentinel axillary lymph nodes and (2) right axillary lymph nodes are negative for tumor. This indicates that there is no regional lymph node involvement, which corresponds to N0.

3. **Distant Metastasis**: There is no mention of distant metastasis in the report, which implies M0.

Based on the TNM classification:
- T2 (tumor size > 2 cm but ≤ 5 cm)
- N0 (no regional lymph node involvement)
- M0 (no distant metastasis)

The combination of T2, N0, M0 corresponds to Stage II according to the AJCC staging system for breast cancer.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
68,"## Answer
To determine the AJCC stage of the cancer, we need to consider the TNM classification provided in the pathology report:

1. **Tumor size (T):** The tumor is described as 1.9 x 1.4 x 1.8 cm, which corresponds to T1c (tumor more than 1 cm but not more than 2 cm in greatest dimension).

2. **Lymph nodes (N):** The report indicates metastases in axillary lymph nodes (No II/XXII), which corresponds to N1a (metastasis in 1-3 axillary lymph nodes).

3. **Metastasis (M):** There is no mention of distant metastasis in the report, so we assume M0 (no distant metastasis).

Using the AJCC 8th edition staging system for breast cancer:
- T1c
- N1a
- M0

This combination (T1c, N1a, M0) corresponds to Stage II breast cancer.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
69,"## Answer
To determine the AJCC stage of the cancer, we need to consider the tumor size, lymph node involvement, and presence of metastasis.

1. **Tumor Size (T):** The report indicates an infiltrating ductal carcinoma with dimensions of 6.0 x 5.0 x 6.0 cm. According to AJCC staging, a tumor larger than 5 cm but not more than 7 cm is classified as T2.

2. **Lymph Node Involvement (N):** The sentinel lymph node #1 is positive for several micrometastases, approximately 0.1 cm each. Micrometastases in lymph nodes are classified as N1mi. Sentinel lymph node #2 and non-sentinel lymph nodes are negative for metastatic tumor.

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, so we assume M0.

Based on the above information:
- T2: Tumor size is between 2 and 5 cm.
- N1mi: Micrometastases in lymph nodes.
- M0: No distant metastasis.

According to the AJCC 8th edition staging system, a T2 N1mi M0 classification corresponds to Stage IIA.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
70,"## Answer
To determine the AJCC stage of the cancer, we need to consider the tumor size, lymph node involvement, and the presence of metastasis.

1. **Tumor Size and Characteristics (T):**
   - The report mentions multiple foci of infiltrating lobular carcinoma with the largest mass being 1.8 x 1.3 x 1.2 cm.
   - The AJCC classification given is pT1c, which indicates a tumor size greater than 1 cm but not more than 2 cm.

2. **Lymph Node Involvement (N):**
   - The report states that one of the three axillary sentinel lymph nodes is positive for micrometastasis, with the largest metastasis measuring 0.6 mm.
   - This is classified as pN1mi, indicating micrometastasis in the lymph nodes.

3. **Distant Metastasis (M):**
   - There is no mention of distant metastasis in the report, so we assume M0.

Based on the AJCC 8th edition staging system for breast cancer:
- T1c (tumor size >1 cm but ≤2 cm)
- N1mi (micrometastasis in lymph nodes)
- M0 (no distant metastasis)

This combination corresponds to Stage IIA breast cancer.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
71,"## Answer
To determine the AJCC stage of the cancer, we need to consider the tumor size, lymph node involvement, and presence of metastasis.

1. **Tumor Size and Characteristics (T):**
   - The report states ""Infiltrating ductal carcinoma, Nottingham grade II (of III), forming a multilobulated mass (1.5 x 1.2 x 1.0 cm)"" and ""AJCC pT1c"".
   - According to AJCC, pT1c indicates a tumor size greater than 1 cm but not more than 2 cm.

2. **Lymph Node Involvement (N):**
   - The report mentions ""Multiple (3 of 25) left axillary lymph nodes are positive for metastatic carcinoma with extranodal extension (AJCC pN1)"".
   - AJCC pN1 indicates metastasis in 1-3 axillary lymph nodes.

3. **Distant Metastasis (M):**
   - There is no mention of distant metastasis in the report, so we assume M0.

Based on the AJCC 8th edition staging system for breast cancer:
- T1c
- N1
- M0

This combination corresponds to Stage II breast cancer.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
72,"## Answer
The pathology report provides the following key information for staging:

1. **Tumor Size (T):** The invasive ductal carcinoma in the right breast is 2.7 cm in greatest dimension. According to AJCC, a tumor size greater than 2 cm but not more than 5 cm is classified as T2.

2. **Lymph Node Involvement (N):** The report indicates ""pN0(i+)"" which means there are isolated tumor cells (ITCs) in the lymph node, but no macrometastasis or micrometastasis. ITCs do not change the N stage from N0.

3. **Distant Metastasis (M):** The report states ""pMx,"" indicating that distant metastasis cannot be assessed from the pathology report.

Based on the TNM classification:
- T2: Tumor size is more than 2 cm but not more than 5 cm.
- N0(i+): No regional lymph node metastasis, only isolated tumor cells.
- Mx: Distant metastasis cannot be assessed.

According to the AJCC staging system, a T2 N0 Mx classification corresponds to Stage II cancer, assuming no distant metastasis is found clinically.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
73,"## Answer
The pathology report provides the following information:

1. The cancer is a poorly differentiated invasive ductal carcinoma, which is a type of breast cancer.
2. There are two tumor foci with diameters of 2.8 cm and 0.8 cm.
3. The tumor classification is given as NOS (Not Otherwise Specified), Grade III (poorly differentiated), pT2(mult)N0M0.

Let's break down the classification:

- **pT2**: This indicates that the primary tumor is more than 2 cm but not more than 5 cm in greatest dimension. The largest tumor is 2.8 cm, which fits this category.
- **N0**: This indicates that there is no regional lymph node metastasis.
- **M0**: This indicates that there is no distant metastasis.

According to the AJCC (American Joint Committee on Cancer) staging system for breast cancer:

- **Stage I**: Typically involves T1 (tumor ≤ 2 cm) and N0, M0.
- **Stage II**: Can involve T2 (tumor > 2 cm but ≤ 5 cm) with N0, M0.
- **Stage III**: Involves larger tumors or regional lymph node involvement.
- **Stage IV**: Involves distant metastasis (M1).

Given the classification pT2N0M0, the cancer fits the criteria for Stage II, as it involves a tumor size greater than 2 cm but not more than 5 cm, with no lymph node involvement and no distant metastasis.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
74,"## Answer
The pathology report provides detailed information about the breast cancer diagnosis. Let's break down the key elements relevant to staging:

1. **Primary Tumor (T):** 
   - The left breast has an infiltrating ductal carcinoma, poorly differentiated, with a size of 6.0 cm. This is classified as pT3 because the tumor is greater than 5 cm in greatest dimension.
   - The right breast has ductal carcinoma in situ (DCIS), which is classified as pTis and does not contribute to the invasive cancer staging.

2. **Regional Lymph Nodes (N):**
   - Sentinel lymph nodes from both axillae were examined, and no carcinoma was found in any of them. Immunohistochemistry for keratin was negative, confirming no lymph node involvement. This is classified as pN0.

3. **Distant Metastasis (M):**
   - There is no mention of distant metastasis in the report, and it is marked as ""not applicable"" or ""Mn/a,"" indicating no evidence of distant spread.

4. **Final AJCC Staging:**
   - For the left breast, the final AJCC staging is pT3, snN0(i), Mn/a. This indicates a large primary tumor with no regional lymph node involvement and no distant metastasis.

Based on the AJCC staging criteria:
- Stage I: T1, N0, M0
- Stage II: T2 or T3, N0 or N1, M0
- Stage III: T4, any N, M0 or any T, N2 or N3, M0
- Stage IV: Any T, any N, M1

The patient's staging of pT3, N0, M0 corresponds to Stage II, as the tumor is large (T3) but there is no lymph node involvement (N0) and no distant metastasis (M0).

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
75,"## Answer
To determine the AJCC stage of breast cancer, we need to consider the tumor size (T), lymph node involvement (N), and presence of distant metastasis (M).

1. **Tumor Size (T):** The tumor size is given as 2.2 x 1.5 x 5 cm. According to AJCC staging, a tumor size greater than 2 cm but not more than 5 cm is classified as T2.

2. **Lymph Node Involvement (N):** The report indicates that 3 out of 5 axillary lymph nodes are positive for metastasis. According to AJCC staging, 1-3 positive axillary lymph nodes is classified as N1.

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, so we assume M0.

Based on the above information:
- T2 (tumor size > 2 cm but ≤ 5 cm)
- N1 (1-3 positive axillary lymph nodes)
- M0 (no distant metastasis)

According to the AJCC 8th edition staging system for breast cancer, a combination of T2, N1, and M0 corresponds to Stage IIB.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
76,"## Answer
To determine the AJCC stage of the cancer, we need to consider the tumor size, lymph node involvement, and the presence of metastasis.

1. **Tumor Size (T):** The report indicates a tumor size of 5.7 x 4.8 x 2.1 cm, which is classified as pT3. According to AJCC, pT3 indicates a tumor larger than 5 cm.

2. **Lymph Node Involvement (N):** The pathology report states that 14 of 16 axillary lymph nodes are positive for metastatic carcinoma, which is classified as pN3. According to AJCC, pN3 indicates metastasis in 10 or more axillary lymph nodes.

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, so we assume M0 (no distant metastasis).

Based on the AJCC staging system:
- T3 indicates a tumor larger than 5 cm.
- N3 indicates extensive lymph node involvement.
- M0 indicates no distant metastasis.

Combining these, the cancer is classified as Stage III.

Therefore, the answer is - 
{""stage"" : ""Stage III""}"
77,"## Answer
The pathology report provides the following key information:

1. **Tumor Size and Type**: The tumor is described as infiltrating ductal carcinoma, poorly differentiated, with a size of 6.0 cm. Poor differentiation typically indicates a higher grade tumor.

2. **Margins and Vascular Invasion**: The tumor extends to within 1 mm of the line of resection and shows massive vascular permeation, which suggests aggressive behavior.

3. **Lymph Node Involvement**: Three out of fifteen axillary lymph nodes are positive for metastatic tumor with capsular and extracapsular extension. This indicates significant lymph node involvement.

4. **No Distant Metastasis Mentioned**: There is no mention of distant metastasis in the report.

Based on the AJCC (American Joint Committee on Cancer) staging system for breast cancer:

- **Stage I**: Typically involves a tumor size of up to 2 cm with no lymph node involvement.
- **Stage II**: Involves a tumor size of 2-5 cm with limited lymph node involvement (1-3 nodes).
- **Stage III**: Involves a larger tumor size (>5 cm) and/or significant lymph node involvement (4 or more nodes, or nodes with extracapsular extension).
- **Stage IV**: Involves distant metastasis.

Given the tumor size of 6.0 cm and the involvement of 3 lymph nodes with extracapsular extension, the cancer is more advanced than Stage II but does not have distant metastasis, which would indicate Stage IV. Therefore, the most appropriate classification is Stage III.

Therefore, the answer is - 
{""stage"" : ""Stage III""}"
78,"## Answer
To determine the AJCC stage of the cancer, we need to consider the tumor size, lymph node involvement, and any distant metastasis.

1. **Tumor Size (T):** The report indicates a tumor size of 3.5 x 3 cm. According to the AJCC staging system, a tumor size more than 2 cm but not more than 5 cm is classified as T2.

2. **Lymph Node Involvement (N):** The report states that 9 out of 10 lymph nodes are positive for metastasis. This indicates significant lymph node involvement. According to the AJCC staging, N2 is defined as metastasis in 4 to 9 axillary lymph nodes. Therefore, this would be classified as N2.

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, so we assume M0 (no distant metastasis).

Based on the above information:
- T2 (tumor size more than 2 cm but not more than 5 cm)
- N2 (metastasis in 4 to 9 axillary lymph nodes)
- M0 (no distant metastasis)

According to the AJCC staging system, a combination of T2, N2, and M0 corresponds to Stage III cancer.

Therefore, the answer is - 
{""stage"" : ""Stage III""}"
79,"## Answer
The pathology report provides the following key information:

1. **Tumor Size and Type**: The tumor is described as an invasive poorly differentiated ductal adenocarcinoma of the breast, measuring 3.2 cm in greatest dimension. This size corresponds to a T2 classification in the TNM staging system.

2. **Lymph Node Involvement**: There is metastatic ductal adenocarcinoma in two out of twelve axillary lymph nodes, with the largest node containing tumor measuring 1 cm and showing extracapsular extension. This corresponds to an N1 classification.

3. **Metastasis**: The report indicates MX, meaning distant metastasis cannot be assessed.

4. **Overall TNM Classification**: The report explicitly states the classification as T2 N1 MX, which corresponds to Stage IIB according to the AJCC staging system for breast cancer.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
80,"## Answer
To determine the AJCC stage of the cancer, we need to consider the tumor size, lymph node involvement, and the presence of metastasis.

1. **Tumor Size (T):** The tumor is described as 1.7 x 1.2 x 1.5 cm. According to the AJCC staging system, a tumor size of 1.7 cm falls under T1c (greater than 1 cm but not more than 2 cm).

2. **Lymph Node Involvement (N):** The report indicates ""Metastases carcinomatosae in lymphonodis axillae (NO IV/X)"" which means there are cancer metastases in 4 out of 10 axillary lymph nodes. This corresponds to N2a, which is defined as metastases in 4 to 9 axillary lymph nodes.

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, so we assume M0.

Based on the above information:
- T1c
- N2a
- M0

According to the AJCC 8th edition staging system for breast cancer:
- T1c, N2a, M0 corresponds to Stage IIIA.

Therefore, the answer is - 
{""stage"" : ""Stage III""}"
81,"## Answer
To determine the AJCC stage of the cancer, we need to interpret the TNM classification provided in the pathology report:

1. **Tumor Size and Extent (T):** The report states ""pT3,"" which indicates that the tumor is more than 5 cm in greatest dimension. However, the report mentions a tumor size of 3.4 cm, which seems inconsistent with pT3. Typically, pT3 would be for tumors larger than 5 cm, but we will proceed with the given classification.

2. **Regional Lymph Nodes (N):** The report states ""pN1a (2/20),"" which means there are metastases in 1 to 3 axillary lymph nodes. Specifically, 2 out of 20 lymph nodes are positive for metastasis.

3. **Distant Metastasis (M):** The report states ""M X,"" which means the presence of distant metastasis cannot be assessed. However, there is no indication of distant metastasis being present.

4. **Other Factors:**
   - ""R 0"" indicates that the resection margins are free of tumor, suggesting complete resection.
   - ""L 1"" indicates lymphatic invasion is present.
   - ""V 0"" indicates no vascular invasion.

Based on the TNM classification:
- T3 (tumor size > 5 cm, although the report mentions 3.4 cm, we use the given pT3 classification),
- N1 (metastasis in 1-3 axillary lymph nodes),
- M0 (no distant metastasis, as M X does not confirm metastasis).

According to the AJCC 8th edition staging system for breast cancer:
- Stage IIIA includes T3 N1 M0.

Therefore, the answer is - 
{""stage"" : ""Stage III""}"
82,"## Answer
The pathology report provides the following key information for staging:

1. **Tumor Size and Characteristics**: The primary tumor in the right breast is described as invasive ductal carcinoma, with the largest focus measuring 3.8 cm. This size corresponds to a T2 classification (tumor size >2 cm but ≤5 cm).

2. **Lymph Node Involvement**: The report indicates that there is metastatic carcinoma in one out of 38 lymph nodes examined (1/38). This corresponds to an N1 classification (metastasis in 1-3 axillary lymph nodes).

3. **Distant Metastasis**: There is no mention of distant metastasis in the report, which implies M0 (no distant metastasis).

Based on the AJCC (American Joint Committee on Cancer) staging system for breast cancer, the combination of T2, N1, and M0 corresponds to Stage IIB.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
83,"## Answer
The pathology report provides the following key information for staging the cancer:

1. **Tumor Size (T):** The invasive ductal carcinoma is 3.3x2.6x2.5 cm, which corresponds to T2 (tumor size more than 2 cm but not more than 5 cm).

2. **Lymph Node Involvement (N):** There is micrometastatic carcinoma in one of the three sentinel lymph nodes (1/3), which corresponds to N1 (metastasis to 1-3 axillary lymph nodes).

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, so we assume M0 (no distant metastasis).

The pathological stage provided in the report is pT2N1a, which aligns with the AJCC staging criteria for breast cancer. According to the AJCC 8th edition, a T2N1M0 classification corresponds to Stage IIB.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
84,"## Answer
To determine the AJCC stage of the cancer, we need to consider the tumor size, lymph node involvement, and any distant metastasis.

1. **Tumor Size (T):** The report indicates an invasive ductal carcinoma measuring 5.0 cm in largest dimension. According to AJCC staging, a tumor greater than 5 cm is classified as T2 or T3, depending on other factors like local extension.

2. **Lymph Node Involvement (N):** The pathology report states that there is no evidence of metastatic tumor in the sentinel node or other examined lymph nodes (0/1 sentinel node, 0/5 level I nodes, 0/5 level II nodes). This indicates N0, meaning no regional lymph node metastasis.

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, so we assume M0.

Based on the above information:
- T2 or T3 (since the tumor is 5 cm, it is likely T2 as T3 is typically for tumors >5 cm with chest wall or skin involvement, which is not noted here)
- N0 (no lymph node involvement)
- M0 (no distant metastasis)

According to the AJCC staging system, a T2N0M0 classification corresponds to Stage II.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
85,"## Answer
To determine the AJCC stage of the cancer, we need to consider the TNM classification provided in the pathology report:

1. **Primary Tumor (T):** The report states ""Primary Tumor: pT2."" According to the AJCC staging system, pT2 indicates a tumor size greater than 2 cm but not more than 5 cm in greatest dimension.

2. **Regional Lymph Nodes (N):** The report states ""Regional Lymph Nodes: pN1a."" This indicates that there is metastasis in 1 to 3 axillary lymph nodes, and/or in internal mammary nodes with microscopic disease detected by sentinel lymph node biopsy but not clinically apparent.

3. **Distant Metastasis (M):** The report states ""Distant Metastasis: Not applicable,"" which implies M0, meaning there is no distant metastasis.

Based on the TNM classification:
- T2
- N1
- M0

According to the AJCC 8th edition staging system for breast cancer, a combination of T2, N1, and M0 corresponds to Stage IIB.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
86,"## Answer
To determine the AJCC stage of the breast cancer from the pathology report, we need to consider the tumor size, lymph node involvement, and presence of metastasis.

1. **Tumor Size (T):** 
   - The report mentions two lesions in the left breast: one measuring 2.6 x 1.7 x 1.5 cm and another measuring 3.0 x 2.8 x 2.5 cm. The larger lesion is 3.0 cm in its greatest dimension. According to AJCC, a tumor greater than 2 cm but not more than 5 cm is classified as T2.

2. **Lymph Node Involvement (N):**
   - The report indicates that there are positive lymph nodes for metastatic carcinoma. Specifically, 2 out of 2 lymph nodes are positive, 1 out of 1 sentinel lymph node is positive, and 5 out of 11 axillary lymph nodes are positive, with three showing extracapsular extension. This suggests significant lymph node involvement. According to AJCC, involvement of 4 to 9 axillary lymph nodes is classified as N2.

3. **Distant Metastasis (M):**
   - There is no mention of distant metastasis in the report, so we assume M0.

Based on the above information:
- T2 (tumor size between 2 and 5 cm)
- N2 (4 to 9 lymph nodes involved)
- M0 (no distant metastasis)

According to the AJCC staging system for breast cancer, a combination of T2, N2, and M0 corresponds to Stage III.

Therefore, the answer is - 
{""stage"" : ""Stage III""}"
87,"## Answer
The pathology report provides the following key information for staging:

1. **Tumor Size (T):** The invasive ductal carcinoma measures 2.2 cm. According to the AJCC staging system, a tumor size of more than 2 cm but not more than 5 cm is classified as T2.

2. **Lymph Node Involvement (N):** There is metastatic carcinoma in one of the sentinel lymph nodes (sentinel lymph node #4), with extranodal extension. The axillary dissection revealed 8 lymph nodes negative for metastases. This indicates N1a, which is defined as metastases to 1-3 axillary lymph nodes.

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, so it is assumed to be M0.

Based on the above information, the pathological stage is pT2 N1a M0. According to the AJCC 8th edition staging system for breast cancer, this corresponds to Stage IIA.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
88,"## Answer
The pathology report provides detailed information about the breast cancer diagnosis. Let's break down the key elements relevant to staging:

1. **Primary Tumor (T):** 
   - The report describes multiple masses in the left breast, with the largest being 3.2 x 2.2 x 1.4 cm. 
   - The tumor does not involve the nipple, overlying skin, or underlying chest wall, and all surgical resection margins are negative for invasive carcinoma by 1.2 cm.

2. **Regional Lymph Nodes (N):**
   - Multiple (10 of 19) left axillary lymph nodes are positive for metastatic carcinoma. 
   - The largest metastasis measures 11.0 mm, and there is no extranodal extension.

3. **Distant Metastasis (M):**
   - There is no mention of distant metastasis in the report.

Based on the AJCC (American Joint Committee on Cancer) staging system for breast cancer:

- **T2**: Tumor size is more than 2 cm but not more than 5 cm.
- **N2**: Metastasis in 4-9 axillary lymph nodes.
- **M0**: No distant metastasis.

Given these findings, the cancer would be classified as Stage III. Stage III breast cancer is characterized by larger tumors and/or significant lymph node involvement but no distant metastasis.

Therefore, the answer is - 
{""stage"" : ""Stage III""}"
89,"## Answer
To determine the AJCC stage of breast cancer, we need to consider the tumor size (T), lymph node involvement (N), and presence of metastasis (M).

1. **Tumor Size (T):** The tumor size is 2.7 x 2.7 x 2.7 cm. According to AJCC staging, a tumor size greater than 2 cm but not more than 5 cm is classified as T2.

2. **Lymph Node Involvement (N):** The report indicates 1 out of 11 axillary lymph nodes is positive for metastasis. According to AJCC staging, 1-3 positive axillary lymph nodes is classified as N1.

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, so we assume M0.

Based on the above information:
- T2 (tumor size > 2 cm but ≤ 5 cm)
- N1 (1-3 positive lymph nodes)
- M0 (no distant metastasis)

According to the AJCC 8th edition staging system for breast cancer, a T2 N1 M0 classification corresponds to Stage IIB.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
90,"## Answer
The pathology report provides the following key information for staging:

1. **Tumor Size (T stage):** The invasive tumor size is 1.5 cm, which corresponds to pT1c (tumor more than 1 cm but not more than 2 cm in greatest dimension).

2. **Lymph Node Involvement (N stage):** There are 0 positive lymph nodes out of 4 examined, which corresponds to pN0 (no regional lymph node metastasis).

3. **Distant Metastasis (M stage):** The report indicates pMX, meaning distant metastasis cannot be assessed, but typically for staging purposes, if there is no evidence of metastasis, it is considered M0.

Based on the AJCC staging system for breast cancer:
- **Stage I** is characterized by T1 (tumor ≤ 2 cm), N0 (no regional lymph node metastasis), and M0 (no distant metastasis).

Given the tumor size (T1c), no lymph node involvement (N0), and no distant metastasis (M0), the cancer is classified as Stage I.

Therefore, the answer is - 
{""stage"" : ""Stage I""}"
91,"## Answer
The pathology report provides the following key information for staging the cancer according to the AJCC (American Joint Committee on Cancer) guidelines:

1. **Tumor Size (T):** The invasive tumor size is 3.8 cm, which corresponds to T2 (tumor more than 2 cm but not more than 5 cm in greatest dimension).

2. **Lymph Node Involvement (N):** There is no carcinoma identified in any of the four sentinel lymph nodes sampled (0/4), which corresponds to N0 (no regional lymph node metastasis).

3. **Distant Metastasis (M):** The report mentions ""pT2N0MX,"" where ""MX"" indicates that the presence of distant metastasis cannot be assessed. However, the report also mentions a ""metastatic high-grade neuroendocrine carcinoma"" in the right chest wall, which suggests the presence of distant metastasis.

Given the presence of metastatic disease, the cancer would be classified as Stage IV, regardless of the T and N classifications, because Stage IV is defined by the presence of distant metastasis.

Therefore, the answer is - 
{""stage"" : ""Stage IV""}"
92,"## Answer
The pathology report provides the following key information for staging the cancer:

1. **Tumor Size (T):** The primary tumor is 2.7 cm in size, which corresponds to T2 in the AJCC staging system (T2: Tumor more than 2 cm but not more than 5 cm in greatest dimension).

2. **Lymph Node Involvement (N):** 
   - One sentinel lymph node is positive for metastatic carcinoma with a focus measuring 0.4 cm.
   - One non-sentinel lymph node is completely replaced by metastatic carcinoma measuring 1.5 cm.
   - This corresponds to N1a (Metastasis in 1-3 axillary lymph nodes).

3. **Distant Metastasis (M):** The report states MX, which means distant metastasis cannot be assessed. However, there is no indication of distant metastasis in the report.

Based on the information provided:
- T2 (tumor size 2.7 cm)
- N1a (metastasis in 1-3 axillary lymph nodes)
- MX (distant metastasis cannot be assessed, but no evidence of distant metastasis is provided)

According to the AJCC staging system, a combination of T2, N1, and M0 (assuming no distant metastasis) corresponds to Stage II breast cancer.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
93,"## Answer
To determine the AJCC stage of the cancer, we need to interpret the provided pathology report using the TNM classification system.

1. **Tumor Size and Extent (T):** The report states ""tumor diameter: 8 cm"" and classifies it as ""pT3"". According to the AJCC staging system, a T3 classification indicates a tumor larger than 5 cm but not more than 10 cm in greatest dimension.

2. **Lymph Node Involvement (N):** The report indicates ""N0"", which means there is no regional lymph node metastasis.

3. **Distant Metastasis (M):** The report does not mention distant metastasis, and typically, if not mentioned, it is assumed to be M0 (no distant metastasis).

4. **Additional Information:** The report mentions ""L0V0R1"", which indicates no lymphovascular invasion (L0), no venous invasion (V0), and a resection margin that is not tumor-free (R1). However, R1 does not affect the staging directly but indicates that the surgical margins are not clear of cancer.

Based on the TNM classification:
- T3 (tumor > 5 cm but ≤ 10 cm)
- N0 (no regional lymph node involvement)
- M0 (no distant metastasis)

According to the AJCC 8th edition staging system for breast cancer:
- T3 N0 M0 corresponds to Stage IIB.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
